Search bioRxiv⌕ Search

Biology subjects

Lehner, B.

Publications and source records attributed to Lehner, B..

At least 19 recordsLinked to original sources

Multimodal allostery in a single-domain protein

Allosteric communication between distant sites in proteins is central to biological regulation and underlies the efficacy of many drugs. Allostery allows proteins to function as molecular switches, with their activities controlled by ligand binding, covalent modifications, and mutations outside their active sites. Allosteric maps have been constructed for several proteins, but these all quantify regulation of a single site in each protein. How the allosteric maps of different sites compare is unclear. Here, we address this question by charting complete allosteric maps for two structurally distant binding sites in the oncoprotein KRAS. Unexpectedly, these maps reveal three different forms of allosteric control, that we term coupled, anti-coupled and independent allostery. Allostery in this small protein is therefore complex and multimodal. The co-existence of multiple allosteric networks in a single-domain protein has important conceptual implications and, if widespread, may allow the development of new classes of therapeutics that not only modulate targets but also tune their functional outputs.

biochemistry↗

Oncogenic fusions induce an extensive cancer-restricted cryptic proteome in Ewing sarcoma

How tumors generate a cryptic "dark" proteome absent from healthy tissues, and whether it can be reversibly activated, remains unclear. In Ewing sarcoma, all tumors are driven by EWSR1::ETS fusions, making it a tractable model to study dark proteome activation. Integrating matched transcriptomes, translatomes and proteomes from 48 patient tumors with long-read RNA sequencing, single-cell Ribo-seq, proteomics and immunopeptidomics in cell line models, we show that EWSR1::FLI1 acts as a reversible switch recurrently inducing hundreds of cancer-specific neoproteins. Many arise from canonical coding regions via intragenic transcription start sites, generating truncated or out-of-frame neoproteins. We uncover a fusion-dependent increase in ribosomal readthrough into poly(A) tails, generating a stable 80-amino-acid TRPM4 neoprotein that, despite lacking a stop codon, is the most abundant tumor-specific microprotein across patients. Proteomic, immunopeptidomic, and immunofluorescence analyses validate neoproteins as tumor-restricted antigens, revealing a therapeutically actionable cancer dark proteome controlled by one oncogenic fusion.

cancer biology↗

Conservation and divergence in the allosteric architectures of five human protein kinases

Protein kinases are central to biological regulation, dysregulated in many diseases, and the targets of a hundred clinically-approved drugs. Structural conservation of kinase active sites makes the development of specific inhibitors challenging. Targeting functional secondary sites can increase specificity, reduce toxicity, overcome resistance mutations, and also activate kinases. However, the functional secondary sites to target in most kinases are unknown, and the conservation of allosteric networks in kinases and other proteins that share the same structural fold is unclear. Here, we quantify the activity and abundance of >160,000 variants to construct complete maps of the energetic and allosteric architectures of five human kinase domains: SRC, FGR, JNK2/MAPK9, ZAK/MAP3K20, and TSSK2. For inhibition, all five kinases have distance-dependent but anisotropic allostery and each kinase has a unique allosteric architecture, surface, and set of pockets to therapeutically target. A set of functional secondary sites is conserved in all five proteins, but other allosteric pockets are protein-specific or switch from inhibitory to activating in different proteins. The differences in the energetic architectures are particularly striking for activation, where the allosteric maps are highly diverged. The allosteric architecture of each kinase is therefore unique, with a distinct set of functional secondary sites to regulate and therapeutically target.

biophysics↗

Complete Mutagenesis of the Genome and Proteome of {Phi}X174

The bacteriophage {Phi}X174 was the first genome to be sequenced and the first to be chemically synthesised. Here we present a complete map of the consequences of changing every nucleotide in the {Phi}X174 genome and every amino acid in the proteome. In total, half of nucleotide and >60% of amino acid changes impair fitness. However, this varies substantially across proteins and non-coding regions. Surprisingly, the most important mechanistic cause of reduced fitness is disruption of protein interaction interfaces, accounting for nearly half of detrimental protein variants. A further one quarter of damaging variants disrupt protein cores but one in four lack a mechanistic explanation. Mutational effects are only moderately-well predicted by state-of-the-art artificial intelligence models, but, combined with structural modelling, provide mechanistic hypotheses and insights into the DNA replication machinery. This complete mutagenesis of a biological system quantifies the limits of our current understanding of, and ability to predict, molecular biology.

genomics↗

The genetic architecture of human programmed stop codon readthrough

Programmed translational readthrough produces C-terminally extended protein isoforms via decoding of stop codons by near-cognate tRNAs. Human genes experimentally validated as readthrough targets share a CUAG motif downstream of a UGA stop codon. However, the full sequence determinants of readthrough efficiency, how they combine, and how generalisable they are across genes remain largely unexplored. Here we use deep mutational scanning to quantify [~]1,400 sequence variants for each of the three examples of human readthrough in the genes AQP4, MAPK10 and OPRK1. In addition to the core CUAG motif, mutations that modulate readthrough elements extend up to +27 nucleotides downstream of the stop codon and across six codons (18 nucleotides) upstream. For the downstream sequence, an additive model with a sigmoidal global epistasis function captures most of the within-gene readthrough variance for double mutants (R{superscript 2}=0.84-0.96), with additional contributions from a small number of strong pairwise interactions. Mutational effects nonetheless generalise poorly between genes: only the immediate -3 to +4 nucleotide window shows consistent behaviour, while mutations in more distal positions have context-dependent effects. Combinatorial assembly of sequence blocks from different genes into chimeras reveals strong interactions (epistasis) between sequences upstream and downstream of the stop codon. This study provides comprehensive quantitative maps of the sequence determinants of human programmed readthrough and suggests that three examples of programmed readthrough are located on distinct local fitness peaks, each defined by different upstream and downstream architectures built around a shared CUAG core motif.

genomics↗

OpenSplice: the impact of half a million mutations on the alternative splicing of 600 human exons

Alternative splicing of mRNA precursors is an important step in gene regulation and a major mechanism by which genetic variants cause human disease. However, changes in splicing have only been quantified for a tiny fraction of possible variants in the human genome, limiting our ability to interpret clinical variants, evaluate and develop machine learning models, and understand the splicing regulatory code. Here, to address this data gap, we present OpenSplice, a well-calibrated experimental dataset that quantifies the impact of >590,000 variants on the splicing of >600 human alternatively spliced exons. OpenSplice increases the number of exons with site saturation mutagenesis data [~]28-fold, quantifying the impact of all possible exonic and proximal intronic single nucleotide (nt) substitutions, as well as all 1, 3, 6 and 21nt deletions. Hundreds of thousands of variants affect splicing and we use the data to evaluate machine learning models, to interpret clinical variants, and to map splicing regulatory architectures. Exons and introns exhibit a broad spectrum of regulatory landscapes, including configurations dominated by enhancers or silencers, checkerboard-like patterns with interleaved enhancers and silencers, and sparse architectures with minimal regulatory content. Silencers are particularly important for determining inclusion levels. OpenSplice provides a complete atlas of variants that impact splicing, a rich testing and training dataset for machine learning models, and a comprehensive map of regulatory elements for mechanistic studies.

genomics↗

Quantitative prediction of nonsense-mediated mRNA decay across human genes by genomic language model and large-scale mutational scanning

The molecular consequences of protein truncating variants depend strongly on whether their transcripts are eliminated by nonsense-mediated mRNA decay (NMD), yet NMD is still predicted largely from a small set of binary positional rules. How individual premature termination codons (PTCs) engage NMD across genes and transcript contexts therefore remains incompletely resolved. Here we integrated endogenous allele-specific PTC expression from large-scale genomic data, mRNA language-model prediction and high-throughput mutational scanning to revisit the rules that govern mammalian NMD. Using allele-specific expression measurements from large human cohorts, we trained NMDetective-AI on [~]14,000 somatic PTCs, and after testing it on [~]1,800 germline PTCs, found that it improves on previous models, with its accuracy approaching the reproducibility of the underlying measurements. We then generated experimental maps of NMD with deep mutational scanning, including [~]450 PTCs nearby the 50-nt penultimate exon boundary, [~]950 engineered PTCs across 9 exon lengths to resolve long-exon escape, and [~]11k PTCs across 139 genes to quantify and refine start-proximal evasion. Our results support the positional logic of mammalian NMD yet show that this logic is implemented quantitatively: the classical rules resolve into graded, gene-dependent response curves whose boundaries are shaped by transcript architecture and modulated by local sequence context. Applying this framework to population, disease and cancer datasets further identifies genes in which NMD is predicted to aggravate or ameliorate the effects of truncating variants, providing a basis for variant interpretation and for prioritizing NMD-directed therapies.

genomics↗

A splice-switching antisense oligonucleotide approach for pediatric genetic epilepsies

Summary ParagraphVariants in ion channel genes are common causes of pediatric epilepsy, often leading to intractable seizures, developmental delay and other comorbidities, which increases risk of death. Pathogenic variants in the SCN8A gene, which encodes a voltage-gated sodium channel critical for action potential generation in the brain, account for [~]1% of genetic epilepsies. The voltage sensor in SCN8A domain 1 is encoded by one of two developmentally-regulated mutually exclusive alternative exons, 5N and 5A. We observe that variants in these exons are more likely to cause infantile spasms, a severe seizure type, than variants elsewhere in SCN8A, and that some pathogenic variants affect exon 5 splicing, impacting patient phenotype. Molecular and evolutionary analyses implicate the exon sequences of these and other voltage-gated ion channel alternative exons in splicing regulation. We identified antisense oligonucleotides (ASOs) that shift splicing of SCN8A exon 5N to 5A or vice versa. These ASOs normalize neuronal activity in patient-derived iPSC neurons, and reduce seizures and motor impairment and extend lifespan in a new exon 5N mutant mouse model. Our results demonstrate that splice-switching ASOs can effectively reduce the expression of pathogenic isoforms and rescue both seizure and non-seizure phenotypes. Similar approaches should be applicable to pediatric genetic epilepsies caused by mutations in other ion channel alternative exons.

neuroscience↗

TF-MAPS: fast high-resolution functional and allosteric mapping of DNA-binding proteins

Transcription factors (TFs) bind specific DNA sequences to control gene expression. Modulating TF activity is of considerable therapeutic interest but very few TFs have been successfully drugged. TF DNA-binding interfaces are large and most TFs have no known allosteric ligands or allosteric sites. Here, we introduce TF-MAPs, a scalable and general platform to chart complete functional maps of sequence-specific DNA-binding proteins. We apply TF-MAPS to three human disease TFs: HNF1A, FOXG1 and FOXP1. Allostery in all three proteins is distance-dependent, anisotropic, and couples the DNA-binding interface to the protein surface. The allosteric surfaces of FOXG1 and FOXP1 are quite diverged, revealing a potential for protein-specific regulation in protein families. All three TFs have potentially druggable pockets where mutations have strong functional effects on binding, either within the binding interface or distant from it. Using TF-MAPS it should be possible to chart functional and allosteric maps for hundreds of human TFs and other DNA-binding proteins to understand DNA recognition and TF regulation, to mechanistically interpret clinical variants, and to guide the development of TF-modulating therapeutics.

genomics↗

Allosteric and Energetic Remodeling by Protein Domain Extensions

Many functions of proteins are performed by independently folding structural units called domains. The structures of domains are conserved during evolution but they are not identical. For example, the >270 human PDZ domains vary in the number of secondary structure elements and in the length of loops. An important but largely unexplored question is the impact of these extensions on protein energy landscapes: beyond any immediate functional effects, do extensions also alter the consequences of perturbations elsewhere in the domain, altering the potential for regulation and evolvability? Here we perform massively parallel energetic measurements on a model human PDZ domain to directly and comprehensively answer this question. In total we quantify the binding to a ligand and abundance of [~]190,000 protein variants to quantify free energy changes for mutations throughout the canonical domain fold and [~]7,000 energetic couplings between these mutations and the two domain extensions, both alone and in combination. We find that both extensions--one structured and one more dynamic--substantially and specifically re-shape the energy landscape of the domain, with the removal of an [a]-helix altering the energetic consequences of 424 mutations in 54 sites on fold stability and 420 mutations in 56 sites on binding to a ligand. These changes to the energy landscape alter the effects of 330 allosteric mutations, including at solvent-accessible surface sites. Extending or pruning the domain therefore reshapes its energetic and allosteric landscape, adding and removing opportunities for the allosteric control of protein function.

biophysics↗

Under which circumstances do genomic neural networks learn motifs and their interactions?

A central challenge in biology is to understand, predict, and engineer the second genetic code: how sequence encodes gene expression. Two components of this challenge are: (1) accurate prediction (and design) of gene expression from sequence and (2) mechanistic understanding of how sequence-to-expression encoding actually works in cells. A powerful general approach to this problem is to combine large scale data generation with artificial intelligence. For example, massively parallel reporter assays (MPRAs) can quantify the expression of thousands of different sequences in pooled experiments and the resulting data can be used to train deep learning models. Unlike in the case of long-context genomic language models, where transformer-based architectures are a dominant paradigm, it remains contested whether for MPRA datasets other architectural components can lead to more useful, generalizable predictors, and whether they affect model interpretability, i.e. the ability to capture causal biological mechanisms (either inherently or when using downstream interpretability or explainability techniques, "xAI"). Ablation analyses may help elucidate important architectural components, but are almost always anecdotal, unable to describe generalizable tendencies, as they are done with a single training dataset or a few testing datasets. Here, we attempt to reconcile concerns and provide guidance for MPRA model design and xAI choice by simulating at scale 1,500 motif-based genetic architectures and evaluating the ability of different model architecture-xAI pairs to first predict an outcome given a sequence as input, and second, report involved motifs and their corresponding grammar. We find that attention-based models are efficient learners, and while we recommend their use in low-data regimes, their performance is surpassed by alternative models, like dilated CNNs, under larger sample sizes. We next show that across grammars and models, current methods for motif extraction converge toward reporting the same set of motifs, which is dominated by motifs with large effect sizes. We then perform in silico experiments across models and their discovered motifs and find that these methods accurately rank motifs based on learned effect size, but that their learned effect size is systematically miscalibrated, particularly in the presence of interactions (epistasis). Finally, we propose a novel metric for identifying motifs involved in epistasis and confirm our findings across three experimental datasets. Our work provides practical guidance for modeling and interpreting massively parallel reporter assay experiments from end to end.

bioinformatics↗

Allostery is a widespread cause of loss-of-function variant pathogenicity

Allosteric communication between non-contacting sites in proteins plays a fundamental role in biological regulation and drug action. While allosteric gain-of-function variants are known drivers of oncogene activation, the broader importance of allostery in genetic disease and protein evolution is less clear. Here, we integrate large-scale experimental measurements and neural network models to provide evidence that allostery is a widespread cause of loss-of-function variant pathogenicity in human genetic diseases. In addition, our analyses reveal a conserved distance-dependent decay of allosteric mutational effects outside of protein active sites. As an important mechanism of pathogenicity, allostery needs to be better mapped, understood, and predicted across the human proteome.

genomics↗

The evolution of allostery in a protein family

Allosteric interactions in proteins are key to biological regulation and the efficacy of many drugs. The extent to which allostery is conserved in evolutionarily-related proteins is unknown, with implications for predicting, engineering and therapeutically targeting allostery. Here we directly address this question by constructing seven comprehensive allosteric maps for five homologous human proteins. The comparative maps reveal a modular allosteric architecture with conserved distant-dependent allosteric decay across the protein core connecting to protein-specific allosteric extensions to surfaces. These allosteric augmentations use both structurally-conserved residues and homolog-specific domain extensions. Our data provide the first comparative multidimensional protein energy landscapes and suggest that allostery evolves via the gain-and-loss of peripheral extensions to a conserved allosteric core.

genomics↗

An intergenerational lipid memory of the social environment in C. elegans

Information about the environment can, in some cases, be transmitted to an organisms offspring by epigenetic inheritance. Here, we describe a novel form of epigenetics in C. elegans where information is transmitted between generations not by alterations in DNA, chromatin, or RNA, but by changes in the composition of lipids. Specifically, we delineate an environment-to-neuron-to-intestine-to-oocyte signalling axis that alters progeny thermotolerance by remodelling lipid provisioning to oocytes when animals detect social pheromones. Intergenerational information transmission via lipid memories may represent an underappreciated form of epigenetics.

genetics↗

The genetic architecture of an allosteric hormone receptor

Many proteins function as switches, detecting chemicals and transducing their concentrations into cellular responses. Receptor switches are key to the integration of environmental signals, yet it is not well understood how their signal processing is genetically encoded. Here, to address these questions, we present a complete map of how mutations quantitatively alter the input-output function of a receptor. Using a massively parallel approach, GluePCA, we quantify more than 40,000 binding measurements and 3,500 dose-response curves for variants of the allosteric phytohormone receptor PYL1. Strikingly, >91% of missense variants tune the dose-response of the receptor. Many variants drive changes in sensitivity, basal activity, maximum response and induction steepness in a correlated manner, suggesting a shared underlying biophysical mechanism, which we identify as stability changes. Beyond this, signalling parameters can be independently tuned by mutations, with surprisingly large effects in interface-distal positions and a modular genetic architecture across the receptors structure. A small subset of missense variants confers qualitative phenotypic innovation, producing hypersensitive and inverted response patterns. Our data demonstrate the feasibility of dose-response profile quantification at massive scale and reveal the remarkable evolutionary malleability of an allosteric switch.

genomics↗

The genetic architecture of G-protein coupled receptor signaling

G protein-coupled receptors (GPCRs) are the largest family of human receptors and drug targets, but how the signaling properties of receptors are encoded in their sequence is incompletely understood. Most GPCR drugs bind a conserved orthosteric pocket, which can result in non-specificity, toxicity and clinical failure. Precision modalities including biased signaling and allosteric modulation could lead to GPCR therapeutics with improved efficacy and safety profiles. The rational design of precision therapies is, however, limited by the lack of high-resolution functional annotation of GPCR structures. Here we present a fast and general approach to rapidly build complete, high-resolution, multi-modal functional and allosteric maps of receptors. The approach, GPCR-MAPS, quantifies direct recruitment of proteins to a receptor and deconvolves the substantial effects of mutations on receptor expression. Applying GPCR-MAPS to the {beta}2 adrenergic receptor generates >150,000 phenotypic measurements, including the full activation functions for all possible amino acid substitutions (>7,500 unique variants) in a single experiment. The multi-modal maps provide numerous mechanistic insights and reveal a modular receptor architecture, with a core activation network surrounded by residues controlling quantitative parameters and bias. The maps also identify multiple allosteric surface pockets, including pockets bound by serendipitously discovered allosteric ligands and a novel pocket with no known ligands. The application of this approach across the superfamily of GPCRs will provide comparative maps of receptor mechanisms and a functional framework for the rational design of precision GPCR therapeutics.

systems biology↗

A pharmacological chaperone stabilizer rescues the expression of the vast majority of pathogenic variants in a G protein-coupled receptor

Reduced protein stability is the most frequent mechanism by which rare missense variants cause disease. A promising therapeutic avenue for treating destabilizing variants is pharmacological chaperones (PCs, also known as correctors or stabilizers), small molecules that bind to and stabilize target proteins. PCs have been approved as clinical treatments for specific variants, but protein energetics suggest their effects might be much more general. Here, we test this hypothesis for the first time by comprehensively quantifying PC efficacy for all missense variants in a human disease gene, the vasopressin 2 receptor (V2R), a G-protein coupled receptor in which loss-of-function variants cause nephrogenic diabetes insipidus (NDI). Strikingly, treatment with a PC rescues the expression of nearly all destabilized variants, with non-rescued variants identifying the drugs binding site. Our results provide proof-of-principle that a single small molecule can rescue destabilizing variants throughout a proteins structure. The application of this principle to other proteins should allow the development of effective therapies for many genetic diseases.

genetics↗

Revolutionizing large-scale DNA synthesis with microchip-based massive in parallel synthesis system

DNA synthesis serves as the fundamental enabling technology of engineering biology, aiming to provide DNA molecules of designed composition, length, and complexity at scale and low cost. Current high-throughput DNA synthesis technologies rely on intricate chip manufacturing and microfluidic systems to provide large-scale synthetic oligonucleotides, at the expense of low concentration and limited compatibility in the processing of longer DNA constructs assembly. Here, we report a microchip-based massive in parallel synthesis (mMPS), pioneering an "identification-sorting-synthesis-recycling" iteration mechanism to microchips for high throughput DNA synthesis. In comparison to microarray-based methods, we demonstrate that our method can increase the DNA product concentration by 4 magnitudes (to picomole-scale per sequence) and greatly simplifies the downstream processes for large-scale gene synthesis construction. By the construction of 1.97 million-diversity variant libraries that cover 1,254 human protein domains, we demonstrated the uniformity of the constructed variant libraries using mMPS-derived oligos is greatly improved, with amino acid distribution highly consistent as designed. In addition, by synthesizing 285 1kb-to-3kb genes with varying degrees of sequence complexity from previously reported strains A501 and 3DAC, potential ancestor of early archaea and bacteria, our result shows that the overall gene assembly success rate using mMPS-derived oligos is increased by 10-fold in comparison to other methods. Our mMPS technology holds the potential to close the gap between the quality and cost of writing DNA in increasing demand across many sectors of research and industrial activities.

synthetic biology↗